CureVac Net Tangible Assets from 2010 to 2026
| CVAC Stock | USD 4.66 0.00 0.00% |
Net Tangible Assets | First Reported 2010-12-31 | Previous Quarter 576.7 M | Current Value 407.8 M | Quarterly Volatility 278.5 M |
Check CureVac NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CureVac NV's main balance sheet or income statement drivers, such as Tax Provision of 34.6 M, Net Interest Income of 14.9 M or Interest Income of 14.9 M, as well as many indicators such as Price To Sales Ratio of 1.51, Dividend Yield of 0.0 or PTB Ratio of 1.16. CureVac financial statements analysis is a perfect complement when working with CureVac NV Valuation or Volatility modules.
CureVac | Net Tangible Assets | Build AI portfolio with CureVac Stock |
Analyzing CureVac NV's Net Tangible Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Tangible Assets has evolved provides context for assessing CureVac NV's current valuation and future prospects.
Latest CureVac NV's Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of CureVac NV over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. CureVac NV's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CureVac NV's overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
CureVac Net Tangible Assets Regression Statistics
| Arithmetic Mean | 238,222,109 | |
| Coefficient Of Variation | 116.92 | |
| Mean Deviation | 258,290,246 | |
| Median | 26,108,000 | |
| Standard Deviation | 278,538,759 | |
| Sample Variance | 77583.8T | |
| Range | 746.1M | |
| R-Value | 0.77 | |
| Mean Square Error | 34091.7T | |
| R-Squared | 0.59 | |
| Significance | 0.0003 | |
| Slope | 42,298,130 | |
| Total Sum of Squares | 1241341.4T |
CureVac Net Tangible Assets History
About CureVac NV Financial Statements
CureVac NV stakeholders use historical fundamental indicators, such as CureVac NV's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although CureVac NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in CureVac NV's assets and liabilities are reflected in the revenues and expenses on CureVac NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CureVac NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | 576.7 M | 407.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Will Biotechnology sector continue expanding? Could CureVac diversify its offerings? Factors like these will boost the valuation of CureVac NV. Projected growth potential of CureVac fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CureVac NV data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.24 | Earnings Share 0.67 | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CureVac NV's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CureVac NV should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CureVac NV's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.